Dry dog, cat food products recalled

May 14, 2007

The U.S. Food and Drug Administration announced the voluntary nationwide recall of various Sensible Choice and Kasco dry dog and cat food products.

The FDA said Royal Canin USA recalled the products after identifying trace amounts of a melamine derivative from tainted Chinese rice protein concentrate provided to the company. Melamine is a chemical used to manufacture plastic and in fertilizers.

The dog and cat food products were sold in 20-pound bags at pet specialty stores nationwide with date codes from July 28, 2007, to April 30, 2008.

The eight recalled Sensible Choice dog food varieties were chicken and rice adult, chicken and rice reduced, lamb and rice reduced, chicken and rice puppy, chicken and rice large breed, adult natural blend, senior natural blend and puppy natural blend.

The six Kasco recalled dry dog food varieties were nks, hi energy, maintenance, mealettes, mini chunks and puppy products. Also being recalled was Kasco dry cat food in 20-pound bags.

Pet owners with questions can contact the company at 800-513-0041 or visit its Web site at www.royalcanin.us.

Copyright 2007 by United Press International

Explore further: Cambodia bans 'virgin surgery' adverts

add to favorites email to friend print save as pdf

Related Stories

Drought sees Rio's main hydro plant turned off

9 hours ago

A major Rio hydroelectric power plant was switched off after water levels slipped below an operational minimum following severe drought, Brazil's national grid told AFP on Thursday.

Recommended for you

Cambodia bans 'virgin surgery' adverts

7 hours ago

The Cambodian government has ordered a hospital to stop advertising so-called virginity restoration procedures, saying it harms the "morality" of society.

What's happening with your donated specimen?

23 hours ago

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.